Stake Purchase

Argonaut enters JW Pharma’s orbit
Oxford spinout Argonaut Therapeutics has received $2.6m from JW Pharmaceuticals in return for a 25% stake.
Des Solutio finds its way out of Nova
Nova University Lisbon has established chemicals producer Des Solutio with the support of Frontier IP, making it the second spinout launched in Portugal by the commercialisation firm.
PGDx intersects with Innovatus in $42m deal
Johns Hopkins oncology diagnostics spinout PGDx had previously raised approximately $99m.
iThera optimises seven-digit round
Medical imaging company iThera spun out of Helmholtz Zentrum München in 2010 and has now been backed by lighting products maker Osram.
Allogene tallies up $120m
The cancer therapy developer has secured $120m in a convertible note offering featuring the University of California office of the chief investment officer.
Forendo fixes up $4.7m round
Vesalius has provided $4.7m to Forendo Pharma, whose existing shareholders also include Karolinska Development, Novartis, Novo and Merck Group.
Pfizer coughs up funding for Biontech
Biontech, an immunotherapy spinout of Johannes Gutenberg University Mainz, has received an undisclosed amount of equity funding as part of a collaboration deal that could reach $425m.

Other News

Millendo overtakes OvaScience in merger deal
Endocrine disease therapy developer Millendo, spun out of University of Michigan, will merge with publicly-listed OvaScience, raising a further $30m in the process.
Frontier IP prints stake in NTPE
Frontier IP will take a 31.8% shareholding in NTPE, an electronics printing technology spinout from Universidade Nova de Lisboa.
Nelumbo laps up Danfoss investment
UC Berkeley advanced materials spinout Nelumbo recently raised $5.5m in series A funding and will now partner Danfoss to develop a heat exchanger based on its materials.
Gadeta glides into Kite partnership
UMC Utrecht spinout Gadeta has partnered cancer drug developer Kite to drive development of its T-cell therapy, allowing Kite to purchase equity from Gadeta's existing shareholders.
TTTech sells stake to B&C
B&C has acquired a 9% stake in TTTech for an undisclosed sum, guaranteeing that the TU Wien spinout will continue to be majority-owned by Austrian shareholders.
Big deal: QuantumScape fuels up on VW cash
VW will invest $100m in QuantumScape and form a joint venture with the Stanford spinout to develop batteries for long-range electric vehicles.

Editor's Picks

Big deal: QuantumScape fuels up on VW cash
VW will invest $100m in QuantumScape and form a joint venture with the Stanford spinout to develop batteries for long-range electric vehicles.
Revolymer sticks to AIM in IPO
Revolymer, which makes chewing gum that is easier to remove from streets and pavements, was backed by the Setsquared Partnership, a joint venture capital initiative between Bath, Bristol, Exeter, Southampton and Surrey.
test reg

Login